IMI2 – Call 2

IMI2 – Call 2 was launched on 6 November 2014 with the following topics under the IMI Ebola and other filoviral haemorrhagic fevers (Ebola+) programme:

  • Vaccine development phase I, II, III
  • Manufacturing capability
  • Stability of vaccines during transport and storage
  • Deployment and compliance of vaccination regimens
  • Rapid diagnostic tests

More information on the topics can be found in IMI’s press release and in the Call text. Other relevant documents, including documents for applicants, the list of expert reviewers, and the independent observers’ reports of the evaluations, can be found on the IMI2 Call documents page.


The projects resulting from IMI2 – Call 2 are:

  • EBODAC - Communication strategy and tools for optimizing the impact of Ebola vaccination deployment
    factsheet | website
  • EbolaMoDRAD - Ebola virus: modern approaches for developing bedside rapid diagnostics
    factsheet | website
  • EBOMAN - Manufacturing and development for rapid access Ebola vaccine
    factsheet | website  
  • EBOVAC1 - Development of a prophylactic Ebola vaccine using an heterologous prime-boost regimen
    factsheet | website
  • EBOVAC2 - Development of a prophylactic Ebola vaccine using an heterologous prime-boost regimen: phase II
    factsheet | website  
  • FILODIAG - Ultra-fast molecular filovirus diagnostics
    factsheet | website
  • Mofina - Mobile Filovirus Nucleic Acid Test
  • VSV-EBOVAC - Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV
    factsheet | website


Call statistics

  • Proposals submitted: 19
  • Inadmissible & ineligible proposals: 5
  • Proposals recommended for funding: 8
  • Proposals not recommended for funding: 6